Overview

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
This study will be performed in approximately 132 women with anovulatory/oligoovulatory infertility.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Ferring Pharmaceuticals
Treatments:
Citric Acid
Clomiphene
Enclomiphene
Hormones
Prolactin Release-Inhibiting Factors
Sodium Citrate
Zuclomiphene